Korea's Health Ministry Gets In The Act To Generate Korean Innovation For U.S. Markets
This article was originally published in PharmAsia News
SEOUL - South Korea's Ministry of Health and Welfare has selected 21 Korean pharmaceutical manufacturers and 17 medical equipment firms to support these companies in the development of globally competitive new drugs, marketing efforts and U.S. FDA approvals needed for their advancement into the U.S. market
You may also be interested in...
In its latest deal for the sale of its hypertension Kanarb product outside Korea, Boryung signed a 10-year deal with China from 2018.
KHIDI deploys pharma experts including former China FDA staffer to provide local Korean pharma with desperately needed advice for global regulatory submissions.
A deal with Sanofi draws upon a 2009 co-marketing deal by Hanmi with Merck & Co. Inc. to pave the way.